CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 93 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,308,000 | -4.7% | 356,889 | -0.9% | 0.01% | -16.7% |
| Q4 2018 | $4,522,000 | -57.1% | 360,289 | -49.3% | 0.01% | 0.0% |
| Q3 2018 | $10,544,000 | +76.2% | 710,482 | +99.8% | 0.01% | -14.3% |
| Q2 2018 | $5,985,000 | -21.9% | 355,629 | +6.3% | 0.01% | -30.0% |
| Q1 2018 | $7,662,000 | +118.7% | 334,573 | +147.1% | 0.01% | +150.0% |
| Q4 2017 | $3,503,000 | +590.9% | 135,399 | +293.9% | 0.00% | +300.0% |
| Q3 2017 | $507,000 | +5.6% | 34,373 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $480,000 | -9.1% | 34,373 | +11.1% | 0.00% | 0.0% |
| Q1 2017 | $528,000 | +108.7% | 30,927 | +25.6% | 0.00% | – |
| Q4 2016 | $253,000 | +1.6% | 24,624 | 0.0% | 0.00% | – |
| Q3 2016 | $249,000 | -10.1% | 24,624 | 0.0% | 0.00% | – |
| Q2 2016 | $277,000 | -8.9% | 24,624 | +10.6% | 0.00% | -100.0% |
| Q1 2016 | $304,000 | -28.0% | 22,268 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $422,000 | +1.0% | 22,268 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $418,000 | +25.9% | 22,268 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $332,000 | +264.8% | 22,268 | +229.9% | 0.00% | – |
| Q1 2014 | $91,000 | – | 6,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |